Carr Patricia
SEC CIK 1784606 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | SVP, Fin, PAO | 6,512 | — | $4.96M | 35 | 2021-08-06 | 2026-03-09 |
Most active insiders at JAZZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COZADD BRUCE C | Dir | — | $27.15M |
| 2 | Iannone Robert | EVP, CMO, Gbl Head of R, D | — | $20.41M |
| 3 | Patil Neena M | EVP, CLO | — | $11.50M |
| 4 | Carr Patricia | SVP, CAO | — | $2.46M |
| 5 | Winningham Rick E | Dir | — | $1.66M |
| 6 | Pearce Samantha | EVP, Chief Commercial Off | — | $1.63M |
| 7 | Henderson Mary Elizabeth | SVP, Technical Ops | — | $1.42M |
| 8 | McSharry Heather Ann | Dir | — | $1.09M |
| 9 | RIEDEL NORBERT G | Dir | — | $655.7K |
| 10 | GALA RENEE D | Pres, CEO | — | $486.1K |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2026-03-05 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | F - Tax | $186.77 | -1,436 | 7,799 | -16% | -$268.2K | |
| 2026-03-09 | 2026-03-09 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $182.94 | -1,287 | 6,512 | -17% | -$235.4K | |
| M | 2026-03-02 | 2026-02-26+ | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $192.60 | -2,370 | 9,235 | -20% | -$456.5K |
| 2026-03-02 | 2026-02-26 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,223 | 11.6K | +24% | $0 | |
| 2026-01-21 | 2026-01-16 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,370 | 9,382 | +34% | $0 | |
| DM | 2025-12-09 | 2025-12-05 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale+OE | $171.20 | -4,660 | 7,012 | -40% | -$797.8K |
| D | 2025-12-09 | 2025-12-05 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | M - OptEx | $140.67 | +4,500 | 11.5K | +64% | +$633.0K |
| DM | 2025-11-20 | 2025-11-18 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale+OE | $182.06 | -5,319 | 7,012 | -43% | -$968.4K |
| D | 2025-11-20 | 2025-11-18 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | M - OptEx | $136.18 | +5,250 | 12.3K | +75% | +$714.9K |
| 2025-03-11 | 2025-03-07 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | D - Sale to Iss | $138.23 | -1,333 | 8,152 | -14% | -$184.3K | |
| 2025-03-11 | 2025-03-10 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $137.81 | -1,140 | 7,012 | -14% | -$157.1K | |
| DM | 2025-03-03 | 2025-02-27 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | M - OptEx | $113.77 | +4,813 | 8,550 | +129% | +$547.6K |
| DM | 2025-03-03 | 2025-02-27+ | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale+OE | $144.27 | -5,586 | 9,485 | -37% | -$805.9K |
| DM | 2025-03-03 | 2025-02-27 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | D - Sale to Iss | $142.43 | -868 | 7,369 | -11% | -$123.6K |
| D | 2025-03-03 | 2025-02-27 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,889 | 10.3K | +39% | $0 |
| 2025-01-22 | 2025-01-17 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +1,641 | 8,237 | +25% | $0 | |
| 2024-12-04 | 2024-12-02 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $122.49 | -53 | 6,596 | -0.8% | -$6,492 | |
| 2024-06-11 | 2024-06-07 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $108.83 | -163 | 6,596 | -2% | -$17.7K | |
| M | 2024-03-08 | 2024-03-06+ | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $118.37 | -3,704 | 8,364 | -31% | -$438.4K |
| 2024-03-05 | 2024-03-01 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,987 | 10.3K | +41% | $0 | |
| 2024-01-19 | 2024-01-17 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +1,327 | 7,363 | +22% | $0 | |
| 2023-08-31 | 2023-08-29 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $143.47 | -142 | 5,986 | -2% | -$20.4K | |
| 2023-08-15 | 2023-08-14 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $138.16 | -158 | 6,128 | -3% | -$21.8K | |
| 2023-06-09 | 2023-06-07 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $127.92 | -126 | 6,286 | -2% | -$16.1K | |
| 2023-03-17 | 2023-03-15 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $133.22 | -1,023 | 6,286 | -14% | -$136.3K | |
| 2023-03-07 | 2023-03-05 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $140.76 | -1,148 | 7,309 | -14% | -$161.6K | |
| 2023-03-07 | 2023-03-03 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,523 | 8,457 | +43% | $0 | |
| 2022-12-07 | 2022-12-05 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $152.06 | -63 | 5,934 | -1% | -$9,580 | |
| DM | 2022-08-17 | 2022-08-15 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale+OE | $160.06 | -2,142 | 5,934 | -27% | -$342.9K |
| D | 2022-08-17 | 2022-08-15 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | M - OptEx | $113.10 | +2,000 | 7,934 | +34% | +$226.2K |
| 2022-08-09 | 2022-08-08 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $152.33 | -158 | 6,076 | -3% | -$24.1K | |
| 2022-06-03 | 2022-06-02 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $150.26 | -131 | 6,234 | -2% | -$19.7K | |
| M | 2022-05-11 | 2022-05-09+ | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | S - Sale | $147.81 | -2,062 | 7,229 | -22% | -$304.8K |
| 2022-03-09 | 2022-03-03 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, CAO | A - Grant | $0.00 | +2,488 | 8,296 | +43% | $0 | |
| 2021-08-10 | 2021-08-06 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | SVP, Fin, PAO | S - Sale | $147.96 | -157 | 6,035 | -3% | -$23.2K |
Purchase Sale Sale after option exercise All abbreviations